top

Contact: lp.surtet@kezsybz

Being Tetrus

Contact

lp.surtet@kezsybz

Spinal cord regeneration information from 2006-2011

Progress in Spinal Cord Regeneration

Breakthroughs in Spinal Cord Treatment

Do Stem Cells Heal the Spinal Cord?

Archive "Progress in Medicine 2006-2011"

22.10.2011
Article from spinalcordinjuryzone.com entitled "Growth Factor Therapy Modifies Cells That Prevent Spinal Cord Repair." (Translation: Sebastian Lizak)

COLUMBUS, Ohio – Scientists at The Ohio State University College of Medicine have discovered that cells in the spinal cord that prevent regeneration following a spinal cord injury (SCI) can be manipulated through gene therapy, causing them to begin supporting the healing of the damaged area.

The study, published yesterday (10/18) in the Journal of Neuroscience, shows that treating spinal cord injuries by genetically delivering high levels of a growth factor to the developing brain can change the behaviour of scar-forming glial cells called astrocytes.

Astrocytes are cells found throughout the brain and spinal cord that normally support nerve cells and help maintain their stability. Following an injury, they protect neurons by forming a scar that acts like a wall separating the damaged area. However, this wall prevents repair when nerve fibres, known as axons, attempt to regenerate.

"We have managed to make astrocytes much more effective at stimulating cell growth following an injury," says Lyn Jakeman, professor of physiology and cell biology and lead author of the study.

Robin White, a graduate student in Ohio State's Neuroscience Graduate Studies Program and a student of Lyn Jakeman, investigated whether increasing levels of transforming growth factor could cause astrocytes to elongate and provide support for growing axons. The key to this idea was newly emerging evidence that immature astrocytes are present in adult mice following an injury and that these immature cells resemble cells that support growth in systems with the greatest regenerative capacity.

"Astrocytes are an excellent target for spinal cord regeneration because they have the potential to become either harmful or supportive to growing axons. Our idea was to make the very young astrocytes already present at the injury site helpful in the regeneration process," says White, who is also the first author of the study.

According to Jakeman and her team, although the research shows promising results in terms of regeneration in mice, limitations still remain regarding the growth of damaged axons in adult animals. Nevertheless, they believe that strategies aimed at modifying the response of astrocytes immediately after spinal cord injury represent a first step in the right direction towards repairing damaged tissue following SCI.

"We hope to learn how the programmes and signalling pathways in these existing immature cells are controlled so that we can use them to regenerate damaged cells," adds Jakeman.

In addition to Jakeman and White, other Ohio State researchers involved in the study included John Gensel, Dana McTigue and Brian Kaspar. Meghan Rao from the Research Institute at Nationwide Children's Hospital also participated in the research.

The research was supported by funding from the National Institutes of Health (NIH), through the National Institute of Neurological Disorders and Stroke, as well as grants from Ohio State's College of Medicine.

12.12.2010
Article from the weekly magazine Przegląd entitled "Experiments with Stem Cells?"

Doctors and investors are eagerly awaiting the results of the first official human trials.

Optimists are talking about a milestone in medical history and the beginning of the era of regenerative medicine. The first official trials of stem cell therapies have begun in the United States and the United Kingdom. Similar human trials are also planned in Switzerland.
Patients who are paralysed or suffering from previously incurable eye diseases have reason to hope.
Shares in the American biotechnology company Geron, based in Menlo Park, California, rose by 19% when it was announced in October that doctors had injected a preparation developed by the company, made from stem cells, into the spinal cord of a paralysed patient. The procedure was performed at Shepherd Center in Atlanta. "This is truly a historic step," said Alan Trounson of the California Institute for Regenerative Medicine enthusiastically. Geron CEO Thomas Okarma predicted: "Living cells are the pills of tomorrow."
The company's specialists obtained cells from a human embryo supplied by an in vitro fertilisation clinic. They multiplied the cells in a laboratory and treated them with hormones and growth-promoting substances, transforming them into a type of precursor cell of the nervous system. They were named GRNOPC1. Geron specialists first conducted experiments on mice and rats. A total of 2,000 rodents with spinal cord injuries were tested. The results were astonishing. Mice and rats were once again able to move their hind legs, which had previously been completely paralysed. "This spinal cord regeneration is permanent," assures Hans Keirstead of the University of California, Irvine, who developed the details of the therapy. Geron subsequently approached the powerful and highly meticulous federal Food and Drug Administration (FDA), a United States government agency responsible for authorising new medicines and pioneering treatments. Geron's application to conduct the first human trials consisted of 21,000 pages. In July of that year, following several months of analysis, the FDA approved the experimental treatment for approximately 10 volunteers. The first trials are preliminary in nature – their purpose is to establish whether the human body will accept GRNOPC1 without harmful side effects. Before the first procedure, the paralysed man received immunosuppressive drugs to prevent the rejection of the transplanted cells. Millions of GRNOPC1 cells were implanted directly into the patient's spinal cord, precisely at the site of the injury. The spinal cord was not completely severed, meaning that the transplanted cells might protect the nerve connections that were still intact. They might also help rebuild those that had been destroyed. This treatment can only be used for spinal cord injuries that occurred no more than a few weeks earlier. After that, scar tissue forms at the site of the damaged nerve connections, preventing neurons from regenerating.
Geron CEO Thomas Okarma warns against excessive expectations: "We do not expect someone who is paralysed from the waist down to be dancing again after six weeks." Given the preliminary nature of the trial, the patient received too small a dose of GRNOPC1 cells for a cure to be expected. Nevertheless, some people are hoping that a medical miracle will occur.

Others are following in Geron's footsteps. The American company StemCells Inc. plans to begin clinical trials in Switzerland using preparations derived from stem cells. This time, the treatment is intended for patients who sustained spinal cord injuries as long as 12 months earlier. When StemCells executives announced the project in mid-November, the company's share price rose by 9%.
Stem cells are considered by many to be the Holy Grail of medicine, capable of curing Alzheimer's disease, Parkinson's disease, diabetes and other conditions affecting humanity in the future. Stem cell therapy may enable people with spinal cord injuries to get out of their wheelchairs, while heart attack and stroke survivors could regain their health and physical abilities. Stem cells have the potential to transform into almost any type of tissue in the human body. In theory, they could be used to grow organs for transplantation or as material for rebuilding damaged areas of the brain and spinal cord. However, this type of therapy raises serious ethical concerns. Stem cells are primarily obtained from human embryos, whether those remaining after in vitro fertilisation procedures, abortions or embryos created specifically for this purpose. The embryos are destroyed in the process of obtaining the cells. This makes it impossible to avoid accusations that human life is being destroyed in order to save the health of others.

So-called adult stem cells can also be obtained from muscles, the spinal cord, the liver, bones and other tissues without destroying embryos. However, they have a more limited ability to differentiate than embryonic stem cells.
Pioneering therapy also carries risks. In a patient's body, stem cells, which are programmed to divide rapidly and intensively, may lead to the formation of numerous cancerous tumours. However, Dr Hans Keirstead reassures the public that Geron used mature, differentiated cells in its experiments, which were almost incapable of further division. "No one in their right mind simply transplants ordinary stem cells," the scientist emphasises.

The experiment at Shepherd Center was conducted officially, with the approval of the authorities. However, it is certain that stem cell treatments are also being performed on humans secretly, in clinics in South and Central America and the Far East. Private clinics in Europe and Russia also offer controversial procedures. At the private X-Cell centre in Düsseldorf, patients suffering from Parkinson's disease pay more than €7,400 for doctors to collect stem cells from their spinal cords and implant them into their brains. In October, an 18-month-old child who underwent experimental treatment at X-Cell died, while two other children were barely saved. The Düsseldorf public prosecutor's office launched an investigation into the doctor responsible for this tragedy. An Israeli couple took their eight-year-old son, who was suffering from an incurable disease, to Moscow for stem cell treatment. The cells were injected into the boy's brain. When the patient was 13, cancerous tumours appeared in his brain and spinal cord. Specialists at Sheba Medical Center in Tel Aviv determined that the implanted stem cells were the source of these tumours. Nevertheless, in various clinics, paralysed patients and people suffering from the effects of strokes pay tens of thousands of dollars for what is, so far, an illusory hope of recovery.
Dr Miodrag Stojković, a renowned stem cell expert working at the Prince Felipe Research Centre in Valencia, is outraged: "Unfortunately, there are self-proclaimed doctors who administer undifferentiated stem cells to patients without any scientific justification." So far, there is no reliable information about the results of these unregulated treatments.
An official experiment, however, was conducted in November by Scottish doctors from the University of Glasgow. For the first time, stem cells were implanted into the brain of a stroke patient. The pioneering treatment was given to a lorry driver who had suffered a stroke 16 months earlier and had become partially paralysed. The stem cells were obtained from an embryo remaining after an abortion performed in California in 2003. The cells were inserted using a 22-centimetre needle, not into the damaged area of the brain itself, but nearby. The team of doctors led by Dr Keith Muir will monitor the patient for two years. Experts believe there are reasons for cautious optimism. Up to 12 people are expected to undergo this type of experimental treatment. If the results are favourable, larger-scale trials will begin.
Dr Anthony Hollander of the University of Bristol described this event as a milestone in the history of British stem cell research. The near future will show whether this remarkable therapy fulfils the enormous hopes placed in it. There are many indications that at least some of the clinical trials will be successful.

Restoring sight to the blind

On 22 November, the FDA granted its second approval for an experimental treatment using differentiated stem cells. The approval was granted to the California biotechnology company Advanced Cell Technology. Company president Robert Lanza is already announcing the beginning of a new era in medicine. Clinical trials are scheduled to begin in January 2011 and will involve 12 patients suffering from Stargardt disease, an incurable condition. This rare hereditary disorder usually affects one in every 10,000 children, causes severe visual impairment and, in extreme cases, leads to blindness. ACT specialists obtained a single cell from an eight-cell human embryo. The embryo was not destroyed and retained its ability to develop normally. This procedure is therefore not as controversial as destroying embryos. Scientists multiplied the embryonic cells and induced them to develop into retinal pigment epithelial (RPE) cells of the eye. Experiments on rats and mice were successful. According to Robert Lanza, the rodents completely regained their ability to see. Soon, RPE cells derived from stem cells will be injected into human eyes. Doctors hope that this method will also prove successful in treating age-related macular degeneration (AMD). This is a very common condition. In both AMD and Stargardt disease, the retinal pigment epithelial cells are destroyed. It is possible that this therapy will help millions of people regain good eyesight.

26.10.2010
Article entitled "Stem Cells Tested on Humans" from rmf24.pl concerning research conducted by the American company Geron

The first clinical trials of a new method of treating spinal cord injuries using stem cells have begun in the United States. A patient at a rehabilitation hospital in Atlanta was selected to participate in the experiment. Six other medical centres in the USA have also declared their readiness to conduct the trials.

The US Food and Drug Administration granted approval for the use of the experimental preparation the previous year. The licence was awarded to the American company Geron, based in San Francisco, which had already spent more than 170 million dollars on research into spinal cord diseases.

The stem cells come from embryos remaining after in vitro fertilisation procedures. They have been modified so that they can develop into nerve cells. Scientists hope that this will enable paralysed patients to regain movement and sensation.

Stem cell therapies are controversial. Opponents emphasise that human embryos are destroyed in the process. Scientists, however, point out that embryonic stem cells could eventually offer hope to people with damage to the nervous system or heart, as well as those suffering from diabetes or Alzheimer's disease.

10.08.2010
Article entitled "Hope for Paralysed People" from kopalniawiedzy.pl concerning experiments conducted at university research centres in the United States.

When Zhigang He of Harvard Medical School regenerated a severely damaged optic nerve in a mouse in 2008, hopes emerged that spinal cord injuries leading to paralysis might be repaired in a similar way.

American scientists have now conducted groundbreaking research that has enabled them to regenerate nerve cells in a damaged spinal cord. Spinal cord injuries, previously considered irreparable, lead to various forms of paralysis.

A team from the University of California, Irvine (UC Irvine), the University of California, San Diego (UC San Diego) and Harvard University developed a technique that effectively "turned back the cellular clock", allowing cells to grow again and regenerate their neural connections. The breakthrough was achieved by removing the PTEN enzyme, which is responsible for controlling the mTOR kinase involved in cell growth. During cell growth, PTEN is relatively inactive. However, once tissue development is complete, PTEN becomes active, blocking mTOR and preventing regeneration if an injury occurs.

Zhigang He, Oswald Steward and Binhai Zheng, together with their research teams, tested the method that He had used in 2008 to regenerate the optic nerve. It turned out that it also worked in the case of the spinal cord.

Until now, such extensive nerve regeneration had not been possible within the spinal cord. Paralysis and loss of function caused by spinal cord injuries were considered irreversible, but our discovery points towards the potential development of a therapy that could enable the regeneration of neural connections following spinal cord injuries in humans, says Oswald Steward.

Scientists are now investigating whether their method actually enables mice to regain motor functions. If it does, the next stage of their research will focus on determining the optimal time to begin treatment and developing methods for delivering the drugs required for the therapy.

28.06.2010
Article entitled "A Breakthrough! Paralysed People Will Soon Be Able to Get Up Again" from niewiarygodne.pl about research aimed at helping people with spinal cord injuries.

This is genuine hope for people confined to beds and wheelchairs. Scientists are working on a special system that will allow paralysed people to move in the same way as healthy individuals. This will be made possible by special chips implanted in patients' brains, which will communicate wirelessly with artificial limbs.

According to scientists, once implanted in the head, such a miniature microchip will "read" the thoughts of a disabled person and transmit signals to an artificial limb. The device, which will be placed in the brain, will be approximately one centimetre wide and will work by analysing neuronal activity, the Daily Mail reported.

According to scientists at the University of Leicester, who are developing this solution, there is a possibility that even people with spinal cord injuries will be able to benefit from this advanced technology.

"A person sees an object and wants to reach for it; they have the intention of reaching it. The brain can send a command to the arm saying, 'grab that cup', but the signal is interrupted at the level of the spinal cord," explained Professor Rodrigo Quian Quiroga, describing the situation faced by people with spinal cord injuries. "However, if we capture the signal from these neurons and process it using what we call a decoding algorithm, we will be able to move a mechanical device positioned in the paralysed arm."

A similar solution had already been tested on animals. However, earlier experiments involving monkeys used wired devices. A cable was connected to the animal's brain and brought out through a small hole drilled in the skull. As Professor Quiroga pointed out, such a solution would not be suitable for humans for aesthetic reasons. Furthermore, drilling a hole in the head could lead to infection.

Scientists believe that a wireless system allowing paralysed people to regain mobility could be tested on patients within the next five years.

24.09.2009
Article entitled "You Don't Need a Brain to Walk or Run" from rp.pl, about experiments on rats that may eventually help people with spinal cord injuries.

Medication, training and electrical nerve stimulation enabled laboratory animals with completely severed spinal cords to move normally.
Experiments on animals may help develop an effective treatment for paralysed people. The achievement described in "Nature Neuroscience" is the work of a team of scientists from Switzerland, the United States and Russia.
The spinal cord is a kind of "cable" that transmits electrical signals from the brain to, among other things, the muscles. There is currently no way to repair a severed spinal cord. However, tests conducted by a team led by Professor Grégoire Courtine from the University of Zurich offer some hope. The scientists used a biological "trick" to activate the rats' legs without involving the brain.
Scientists had previously observed that certain simple movements could be performed without electrical signals coming from the brain. It was as if all the components necessary for such movements were already present in the spinal cord below the site of the injury. "This research confirms that part of the spinal cord contains its own circuits that enable movement," explains Professor Reggie Edgerton, a member of the research team from the University of California.
The paralysed rats were placed in special harnesses supporting their bodies and positioned on a treadmill. They were given an injection of medication that increased spinal cord activity, and their spinal cords were gently stimulated with electrical impulses. This was enough to make their legs start moving on their own. Initially, their gait was rather clumsy. However, after nine weeks of locomotor training on a treadmill, the steps of the paralysed rats were just as flexible as those of healthy animals.
"The most exciting thing is that, for the first time, they managed to make these rats walk normally without any involvement of the brain whatsoever," explains Susan Howley of the Christopher and Dana Reeve Foundation, which partly funded the research. However, Professor Courtine himself believes that a similar treatment method will not be used in humans for several years. It will probably be combined with an advanced electronic neuroprosthesis connecting the brain to the severed spinal cord.

11.08.2009
Article entitled "Hope for a Treatment for Spinal Cord Injuries", concerning the regeneration of neural connections in a damaged spinal cord.

Scientists in the United States report in the journal "Nature Neuroscience" that they have succeeded in reconnecting damaged (severed) spinal cord nerves in a rat.
Spinal injuries that result in severed spinal cord nerves can lead to complete paralysis of the limbs. The inability to repair such an injury is most often associated with the loss of connections between the brain and other parts of the body. Unfortunately, spontaneous nerve regeneration is not possible in such cases.
Previous attempts to restore neural connections between different parts of the body and the brain have achieved only partial success. Although nerve regeneration sometimes occurred, the regenerated nerves were often unable to establish their proper function in the appropriate target areas of the brain.
Mark Tuszynski and his team from the University of California, San Diego, managed under laboratory conditions to reconnect sensory nerves with their target location in the so-called brainstem following spinal cord injury in rats.
The scientists drew on knowledge of normal brain development. To stimulate nerve growth, they used a naturally occurring protein called neurotrophin-3. In addition, they provided the growing nerves with transplanted bone marrow cells, which acted as a bridge. In this way, they succeeded in achieving complete anatomical regeneration of the damaged neural pathway.
Although the authors of the study did not restore full sensation in the animals' limbs (despite the regeneration of the connection), their discovery should help in developing methods for restoring fully functional neural connections following spinal cord injuries.

9.03.2009
Article entitled "What Will the Outcome Be?", concerning the transplantation of stem cells into a damaged spinal cord.

Late August 2008. An operation is underway at the Department of Neurosurgery at the Medical Academy in Wrocław. The patient is a 27-year-old man, almost completely hidden beneath green sterile surgical drapes. The steady hum of respiratory support equipment can be heard, along with the doctors' brief comments and the clatter of surgical instruments.
Just another operation? No. It could mark a breakthrough in medicine. It is the second procedure of this kind in Poland and one of only a handful performed worldwide. An eight-member team led by Professor Włodzimierz Jarmundowicz began work early in the morning and will finish in the evening. Almost 11 hours at the operating table! The procedure involves transplanting the patient's own olfactory ensheathing glial cells into his spinal cord, which was damaged in a road accident. If the operation produces the expected results, Krzysztof Pietrzyk could become one of the first patients in the world to stand up and walk again using his own strength.

Krzysztof Pietrzyk comes from Kielce. Five years earlier, he had been a second-year Physical Education student at the Świętokrzyska Academy. He trained in bodybuilding, strength sports and basketball. He had all the makings of a good physical education teacher. He was in excellent physical shape: at 180 cm tall, he weighed 81 kg. He loved motorcycles. With the first money he had saved, he planned to buy a Kawasaki 750.
The accident happened on 22 April 2003 in Mniów, near Kielce. Krzysztof was riding alone, too fast, when he lost control on a bend. When he regained consciousness, he was lying on the grass with people moving around him. He felt no pain, but he could not feel his legs either. An ambulance arrived shortly afterwards. Initial examinations were carried out in Kielce, where doctors diagnosed a spinal cord injury at the level of the sixth and seventh thoracic vertebrae. Krzysztof was transferred to a hospital in Piekary Śląskie, where an operation to stabilise his spine was performed.

Krzysztof Pietrzyk He returned home in the autumn, already using a wheelchair. Continuing his studies at his previous university was impossible, so he transferred to the University of Physical Education in Katowice. Its Faculty of Management offered a specialisation in physiotherapy. He graduated in 2008, so he would not have to face the prospect of being an unemployed disability pensioner. While studying in Katowice, he returned to basketball, this time in a wheelchair. He plays for a club in Chorzów and represents Poland in international competitions. At the European Championships in Germany, his team finished ninth in Group A, the top division.
Wheelchair basketball is a tough sport. He plays because he loves movement, physical exertion and the excitement of competition. However, nobody could have predicted that basketball would be precisely what led to Krzysztof being selected for this historic operation.

An experiment on a human being
Around the same time that Krzysztof Pietrzyk was considering buying his Kawasaki in Kielce, a team of doctors in Wrocław led by Professor Jarmundowicz was beginning a new stage of research into olfactory ensheathing glial cells. They had been interested in these cells for a long time, as had the entire medical research community. The cost of the research, including the transplants performed that year, was covered by a grant awarded by the Committee for Scientific Research.
"We already knew in the nineteenth century that olfactory ensheathing glial cells were present in the mucous membrane of the human nose, but for several decades their function in the body remained unknown," says Professor Jarmundowicz. "It was only in the 1980s that Professor Raisman in London demonstrated that these cells are responsible for the regeneration of the olfactory epithelium."
How this happens is still not fully understood. Olfactory cells are a kind of extension of the brain, much like the cells of the retina. Retinal cells do not regenerate after being damaged. Functional regeneration of spinal cord nerve fibres does not occur either. Olfactory cells, however, possess this ability. We know that people lose their sense of smell many times throughout their lives, for example as a result of a cold, burns to the upper respiratory tract or inhalation of toxic substances. After several days or weeks, their sense of smell returns. The same happens in animals. This is probably an ancient evolutionary adaptation, necessary because of the great importance of the sense of smell for the survival of a species.
The first animal experiments were carried out in Spain and Portugal as early as the 1990s. A short video can still be found circulating on the internet. It shows a rat whose spinal cord was first severed and which was subsequently given experimental treatment involving the transplantation of olfactory cells. The rat can be seen energetically climbing a metal mesh using all four legs! Another control animal, which received no treatment, still has completely paralysed hind legs. Experiments on monkeys were also conducted in Spain, at a research centre in Valencia. They were suspended, partly due to protests from animal welfare advocates, but research has continued.
"We also conducted research on rats here in Wrocław," says Professor Jarmundowicz, "and obtaining approval from the Bioethics Committee was by no means easy. However, this research, which lasted several years, had a different objective. We wanted to make sure that the transplantation of olfactory cells was a safe form of treatment. There could be many potential risks: tumours of nervous tissue, necrosis and purulent inflammation. None of these occurred in the animals we observed. This opened the way for an experiment – although the term may sound rather controversial – on human beings."

Fears and expectations
Candidates for the operation were selected according to strict criteria. They had to be young people in generally good health whose spinal cord injuries had occurred no more than a few years earlier. A high level of stress tolerance and psychological stability were desirable. Because intensive rehabilitation was required both before and after the procedure, candidates also had to be physically fit. Ideally, they should have been involved in sports. The most important requirement was that all spinal cord function below the level of the injury had to be completely absent. As is known, in cases of incomplete spinal cord injuries, particularly when intensive physical rehabilitation is undertaken, undamaged neural pathways can regain their functions. For the purposes of this experiment, such a possibility had to be excluded in the interest of scientific research. Of the 50 candidates examined, two were selected who best met these criteria.
"We underwent several days of very thorough examinations," recalls Krzysztof Pietrzyk, "including computed tomography and magnetic resonance imaging. During these examinations, a sample of my olfactory epithelium was also taken from inside my nose. I cannot say much about the procedure because I was under general anaesthesia. Later, I learned that specialists working with the Institute of Immunology and Experimental Therapy spent the next three weeks identifying my olfactory cells, multiplying them and staining them in preparation for the transplant. They obtained several million cells, which were stored at a very low temperature until the day of the operation."

Krzysztof Pietrzyk undergoing rehabilitation treatment. Several weeks before the operation, Krzysztof began an intensive physical rehabilitation programme. Gymnastics, massages, light therapy, baths and electrical stimulation – he received everything that modern physiotherapy had to offer. The aim was to prepare his muscles and joints for the intensive exercises that would begin after the operation. The treatments took place in Wrocław, at the "Akson" Rehabilitation Centre for Spinal Injuries and Diseases, located at 23 Bierutowska Street. Krzysztof Pietrzyk lived in a small room on the first floor of the same building. The building had a lift and was well adapted to the needs of wheelchair users. In theory, he could have stayed there for several months without going outside, undergoing treatment from morning until evening. But that proved impossible: the tension increased as the date of the operation approached. He would get into his VW Golf, adapted for hand controls, and drive aimlessly around Wrocław. He could not come to terms with the thought that he was going to become one of the first people in the world to undergo such a procedure.
"It is no longer just about me," he says, "but about thousands of people in wheelchairs who are waiting for the outcome of this experiment with the same anxiety that I feel. What if nothing comes of it? Will all this hope have been in vain? Of course, the medical team warned us that many months might pass before any signs of improvement could be observed. And that there might be no improvement at all. The professor did not say it directly, but I knew very well what he meant: this experiment produces wonderful results in rats, but people are not rats, and medicine is still dealing with these issues through trial and error."

Professor Jarmundowicz "At the beginning of the operation," says Professor Jarmundowicz, "we first had to expose the spinal cord and remove the glial scar and adhesions. Once this had been done, we began injecting the olfactory cells into the spinal cord. A total of 120 injections were performed. Each dose contained approximately 25,000 cells. The procedure was carried out using a stereotactic technique, which means that a frame was used to determine the precise location and depth of each injection. The transplant cells were prepared by our colleagues from the Institute of Immunology, who were present in the operating theatre. A total of eight doctors took part in the operation, including two supporting doctors who documented the procedure photographically and recorded it on video. We plan to perform another two or three similar operations over the coming year. Naturally, we are also preparing scientific publications on this subject for specialist journals. Throughout this year, we will carefully monitor both patients to make sure that no unwanted side effects occur. We must be absolutely certain that this procedure is safe for use in humans. This will conclude the first phase of the experiment. Only then will we be able to proceed to the second phase, namely clinical trials. Following our experimental procedures, we received hundreds of letters and telephone calls from all over the world. Everyone wanted to know when we would be able to move on to the second phase of research. This will not be possible for at least another two years, provided everything goes according to plan."

Officials throw up their hands
"And there is also the daily session of 'hammering'," adds Krzysztof Pietrzyk, using a vivid description. "This involves repeatedly striking the nerve plexuses located below the knees with a rubber mallet."
Recently, Krzysztof began practising walking between parallel bars. His colleague, who underwent the same operation two months earlier, is already training on a treadmill. Yes, the legs are moving, but for now these are movements produced by external stimulation. Voluntary movements are not yet possible.
So does this mean there is no good news for the thousands of people waiting for updates from Wrocław? "Actually, I have noticed some improvement during certain exercises," says Krzysztof Pietrzyk. "For now, the changes are so minimal that I cannot really describe them. My physiological functions have improved. I use the toilet more frequently and regularly. It is not yet known whether this is the result of more intensive rehabilitation exercises or perhaps the reconstruction of neural connections."
Of course, someone has to pay for all these treatments. And the costs are substantial: approximately PLN 200 per day, or around PLN 5,000 per month. Accommodation at the Rehabilitation Centre costs an additional PLN 1,500 per month. To save money, Krzysztof Pietrzyk prepares his own meals. It is difficult to blame him, considering that his disability pension amounts to just PLN 470. Without his family's help, Krzysztof would not be able to afford such intensive rehabilitation.
Krzysztof's mother, Maria Pietrzyk, is a nurse. She cares for him together with his 26-year-old sister. His father has left the family.
"For months, I have been writing applications and letters asking for financial support. We received some money from sponsors, but those funds are already running out. I have not lost hope that I will manage to obtain financial assistance from the National Health Fund, PFRON or wherever else possible," says Mrs Maria. "This is Poland. Officials just throw up their hands and say that the regulations need to be changed... There is one thing I cannot understand. Preparations for these operations, the examinations and the transplant experiments took many years and cost hundreds of thousands, if not millions. Did nobody think about providing a few thousand zlotys a month for the patients' rehabilitation? About the fact that very few people in Poland can afford such expenses, even when their health is at stake?"

Everyone interested in this groundbreaking transplant is asking similar questions.

30.08.2008
Article entitled "A Man from Kielce Has Been Given a Great Chance at a New Life"

A man from Kielce who had been paralysed for five years underwent an operation on Tuesday to receive a transplant of glial cells. It was the second operation of this kind in Poland.

The method was developed by doctors from the Department of Neurosurgery at the Medical Academy in Wrocław and represents a major opportunity for people who use wheelchairs. The Wrocław team spent four years preparing to perform this type of operation. At the end of June, they operated on the first patient with a severed spinal cord. A month and a half later, on Monday, 18 August, they operated on Krzysztof Pietrzyk from Kielce. The operation lasted 12 hours.

CONFINED TO A WHEELCHAIR

Krzysztof was a university student when he was involved in a motorcycle accident five years ago. His crushed spinal cord left him confined to a wheelchair. It was his mother, Maria, a nurse, who found information about glial cell transplants that might offer a chance of restoring movement in her son's legs. She began efforts to have him qualified for the procedure. Krzysztof had the advantage of being young and in good physical condition. This is why, after a rigorous selection process conducted by Professor Włodzimierz Jarmundowicz, he was selected for the operation as one of only four people in Poland.
This unique operation begins with the cultivation of olfactory ensheathing glial cells (OEG cells). Although damage to the central nervous system is irreversible, glial cells found in the nose are the only cells of the nervous system capable of regenerating. This was demonstrated in animal experiments: paralysed rats with severed spinal cords that received OEG cell transplants regained the ability to move.
The operation begins with the removal of olfactory tissue from the nose. Olfactory glial cells are then cultured from the epithelium isolated from this tissue. This process takes several weeks. During Monday's operation, which lasted several hours, the doctors performed more than 100 injections into the spinal cord. Each time, they injected approximately 25,000 olfactory cells, intended to stimulate the regeneration of nervous tissue in the spinal cord.

WE ARE WAITING WITH HOPE

"Krzysiek has woken up, but he is weak after such a long procedure," his mother told us yesterday. She has not left her son's side at the Wrocław clinic. "The doctors said that we will have to wait between three months and two years to see the results of the operation. We remain optimistic."

The only thing keeping mother and son awake at night is money. The operation was expensive, and rehabilitation is now necessary. Each month of rehabilitation costs PLN 7,000. The Building School No. 1 in Kielce, where Mrs Maria works, helped Krzysztof and his mother raise funds for the operation. The Foundation for the Development of Surgery made its bank account available for donations. "I believe that donors will come forward, because the National Health Fund covers only a small part of the costs," says Maryla Gładysz, the school's headteacher.

27.06.2008
Article entitled "Paralysed Patients Have Received a Transplant of Hope"

Will a person with a severed spinal cord be able to walk? Doctors in Wrocław have been working on this for four years. On Thursday, they performed the first operation in Poland to transplant nerve cells taken from the nose into the spinal cord.

"A new hope has emerged for wheelchair users for whom medicine has so far been unable to offer a solution," says Professor Włodzimierz Jarmundowicz from the Department of Neurosurgery at the Medical Academy in Wrocław, who is leading the research programme.

Four years ago, a young man from Wrocław had his spinal cord severed with a knife. He was paralysed from the waist down. Since then, he has been using a wheelchair. He was selected for the operation partly because of his young age and good general health. Fifty other patients who had previously participated in the research programme led by Professor Jarmundowicz were excluded during the selection process.

Scientists have high hopes for olfactory ensheathing glial cells (OEG cells), which are found in the nasal mucous membrane. Their structure was already known at the end of the nineteenth century, but their function remained unclear for a long time. It was only research conducted in the 1980s by Professor Geoffrey Raisman of the National Institute for Medical Research in London that demonstrated that these cells are responsible for the regeneration of the olfactory epithelium. The epithelium, which enables us to distinguish different smells, is constantly damaged by injuries and inflammation, but it regenerates within a few weeks thanks to OEG cells.

"Damage to the central nervous system is irreversible," says Professor Jarmundowicz. "Yet it has turned out that the glial cells in our noses are the only part of the nervous system capable of regenerating. Paralysed rats with severed spinal cords that received OEG cell transplants began climbing up wire grids again."

Scientists are trying to use this remarkable property of cells from the nose to regenerate damaged fibres in the spinal cord. This offers hope to people with completely severed spinal cords, including victims of car accidents and dives into water that is too shallow.

"Every year in Poland, 700 people end up in wheelchairs for this reason. Until now, there has been no effective way of restoring sensation and motor function in these patients. Intraspinal transplantation of olfactory ensheathing glial cells is a breakthrough in neurosurgery and offers a measure of hope to paralysed people, including our patient," the professor told us yesterday, an hour before the operation.

The 26-year-old man first had olfactory tissue removed from his nose. The epithelium was isolated from it and used to culture OEG cells. The transplant material consisted of a mixture of cells cultured over the previous weeks and cells that had been frozen two years earlier and were now thawed. Yesterday, during a long and painstaking operation involving seven doctors, the patient received 120 injections into his spinal cord. Each contained approximately 25,000 olfactory cells intended to stimulate nerve regeneration. However, it will only become clear after a year whether the man will be able to move his legs.

The operation was preceded by four years of research conducted by scientists from the Department of Neurosurgery at the Medical Academy and the Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences in Wrocław. Through in vitro experiments, studies on rats and research using olfactory epithelium taken from deceased organ donors, the scientists developed a method for collecting, selecting and multiplying cells that subsequently survived in nervous tissue. Their safety was also tested: they did not cause tumours or inflammation in the animals.

"This is an entirely experimental procedure," says Professor Jarmundowicz.

Three such operations have been performed so far in Melbourne, but their results have not yet been announced. Similar operations, using a slightly different method, have been carried out in recent years in Lisbon and London, but the results are still being monitored there as well.

"This is a long process," says the professor. "We are only at the beginning of the road."

Source: Gazeta Wyborcza Wrocław

30.09.2007
Article entitled "Transplants Using Stem Cells Taken from Adult Bone Marrow Restore Functions in Patients with Spinal Cord Injuries; PrimeCell(TM) Therapeutics Announces That Research Will Continue"

Monday, 24 September.
Preliminary results of transplants performed on 38 patients were presented during the annual meeting at the Neurological Congress.

IRVINE, California. PrimeCell(TM) Therapeutics LLC (http://www.primecelltherapeutics.com) announced today that it is supporting research for clinical trials involving the implantation of the patient's own bone marrow-derived stem cells into an injured spinal cord. The reported results of these trials include the recovery of various functions in patients who had been paralysed for between 4 and 22 years.

Dr Luis Geffner presented a preliminary report on the findings on 17 September at the Neurological Congress in San Diego. Between May 2006 and August 2007, 38 patients with spinal cord injuries were treated in Ecuador at Luis Vernaza Hospital in Guayaquil. They received autologous bone marrow stem cells, meaning that the cells were taken from their own bone marrow, collected from the hip bone.

Of the 25 patients monitored for between 3 and 14 months, 15 regained the ability to stand, 10 were able to walk with braces, seven could walk without braces and five could walk using crutches. Three patients regained full bladder control, while 10 experienced the return of some sexual function. No adverse events or abnormal reactions to the implantation were observed.

"Ongoing research will help us clarify the benefits and any possible risks associated with this approach. However, so far, the findings indicate that bone marrow stem cells are safe for patients with spinal cord injuries," said Geffner, head of the stem cell programme at Junta de Beneficencia de Guayaquil.
He emphasised that the work had been completed with the assistance and support of Junta de Beneficencia and Benemérita Sociedad de Lucha Contra el Cáncer (SOLCA), as well as through the support and research carried out by PrimeCell Therapeutics, based in Irvine, California.

"By implanting adult bone marrow stem cells, we have seen significant improvements in the quality of life of people suffering from spinal cord injuries. In addition, we are gaining valuable information that will ultimately help us use other adult cells in the treatment of spinal cord injuries and reprogramme adult embryonic cells," said Francisco Silva, Vice President of Research and Development at PrimeCell Therapeutics. "We are encouraged by the results. This approach may be useful for patients who cannot be treated using conventional medicine."

7.07.2007
Article entitled "Attempts to Repair Spinal Cord Damage"

Hywel Griffith, BBC Wales Health Correspondent.
The trials are to be carried out on the first patients as part of cell research that could help thousands of people paralysed following accidents.
The Welsh charity Trust PA has helped fund scientists who hope to repair the spinal cord by transferring cells from the nose so that they can grow at the site of an injury.
If successful, the treatment could mean that patients regain control over their bodies. The research is being conducted by the Institute of Neurology in London.

Simon Morris, from Sully in the Vale of Glamorgan, has been learning to live a new life since an accident ten years ago left him paralysed from the chest down. A simple fall during a holiday in Greece was enough to damage his spinal cord. He spent 16 months in hospital and is now dependent on a wheelchair.

"I was in the Navy before my accident, so I was quite active. I really enjoyed socialising," said Mr Morris.
"Having all of that taken away in an instant was too much for me."
"Improving my mobility would be brilliant. Any small improvement, however slight, would mean a great deal to me — not just to me, but to other people with spinal cord injuries."

Animal trials

There is currently no treatment for Morris's injury, but Professor Geoffrey Raisman of the Institute of Neurology has said that cells found in the nose can be transplanted into the spinal cord and may help it regenerate.
So far, the tests have been carried out on animals, but Professor Raisman said that the team was ready to begin trials on humans.
"We have reached the point where animal trials — on rats — may allow us to obtain these cells from adult animals," he said.

"We can transplant them into spinal cord injuries, at the spinal roots, and the nerve fibres regenerate and functions return."

"We are now trying to take this approach into human trials," he added.

The stage we and others have reached shows that these cells are present in humans. We are learning how to multiply them using samples taken from volunteers, and then we hope to transplant them into a group of 10–12 patients with high-level spinal cord injuries.
The research is expensive and is supported by a small Welsh charity.

Trust PA was founded in memory of Paul Andre (PA) Blundell, a Cardiff rugby player who was paralysed after an accident on the pitch.

After his death five years ago, his parents decided to support efforts to fund research into spinal cord regeneration.
His mother, Gerri Blundell, said: "We have enormous hope because Geoffrey Raisman's work is backed by 40 years of research.
As far as Paul Andre was concerned, there was a chance that he might walk again before reaching the age of forty. He thought it was worth going through the procedure, and I believe that, for other families, hope is one of the most important things everyone needs in life.
Developing the research may still take years, but financial support will help it move forward. Fundraising events also play a role, including events such as the British Speedway Grand Prix held last weekend."

30.08.2008
Article entitled "A Man from Kielce Has Been Given a Great Chance at a New Life"

A man from Kielce who had been paralysed for five years underwent an operation on Tuesday to receive a transplant of glial cells. It was the second operation of this kind in Poland.

The method was developed by doctors from the Department of Neurosurgery at the Medical Academy in Wrocław and represents a major opportunity for people who use wheelchairs. The Wrocław team spent four years preparing to perform this type of operation. At the end of June, they operated on the first patient with a severed spinal cord. A month and a half later, on Monday, 18 August, they operated on Krzysztof Pietrzyk from Kielce. The operation lasted 12 hours.

CONFINED TO A WHEELCHAIR

Krzysztof was a university student when he was involved in a motorcycle accident five years ago. His crushed spinal cord left him confined to a wheelchair. It was his mother, Maria, a nurse, who found information about glial cell transplants that might offer a chance of restoring movement in her son's legs. She began efforts to have him qualified for the procedure. Krzysztof had the advantage of being young and in good physical condition. This is why, after a rigorous selection process conducted by Professor Włodzimierz Jarmundowicz, he was selected for the operation as one of only four people in Poland.
This unique operation begins with the cultivation of olfactory ensheathing glial cells (OEG cells). Although damage to the central nervous system is irreversible, glial cells found in the nose are the only cells of the nervous system capable of regenerating. This was demonstrated in animal experiments: paralysed rats with severed spinal cords that received OEG cell transplants regained the ability to move.
The operation begins with the removal of olfactory tissue from the nose. Olfactory glial cells are then cultured from the epithelium isolated from this tissue. This process takes several weeks. During Monday's operation, which lasted several hours, the doctors performed more than 100 injections into the spinal cord. Each time, they injected approximately 25,000 olfactory cells, intended to stimulate the regeneration of nervous tissue in the spinal cord.

WE ARE WAITING WITH HOPE

"Krzysiek has woken up, but he is weak after such a long procedure," his mother told us yesterday. She has not left her son's side at the Wrocław clinic. "The doctors said that we will have to wait between three months and two years to see the results of the operation. We remain optimistic."

The only thing keeping mother and son awake at night is money. The operation was expensive, and rehabilitation is now necessary. Each month of rehabilitation costs PLN 7,000. The Building School No. 1 in Kielce, where Mrs Maria works, helped Krzysztof and his mother raise funds for the operation. The Foundation for the Development of Surgery made its bank account available for donations. "I believe that donors will come forward, because the National Health Fund covers only a small part of the costs," says Maryla Gładysz, the school's headteacher.

27.06.2008
Article entitled "Paralysed Patients Have Received a Transplant of Hope"

Will a person with a severed spinal cord be able to walk? Doctors in Wrocław have been working on this for four years. On Thursday, they performed the first operation in Poland to transplant nerve cells taken from the nose into the spinal cord.

"A new hope has emerged for wheelchair users for whom medicine has so far been unable to offer a solution," says Professor Włodzimierz Jarmundowicz from the Department of Neurosurgery at the Medical Academy in Wrocław, who is leading the research programme.

Four years ago, a young man from Wrocław had his spinal cord severed with a knife. He was paralysed from the waist down. Since then, he has been using a wheelchair. He was selected for the operation partly because of his young age and good general health. Fifty other patients who had previously participated in the research programme led by Professor Jarmundowicz were excluded during the selection process.

Scientists have high hopes for olfactory ensheathing glial cells (OEG cells), which are found in the nasal mucous membrane. Their structure was already known at the end of the nineteenth century, but their function remained unclear for a long time. It was only research conducted in the 1980s by Professor Geoffrey Raisman of the National Institute for Medical Research in London that demonstrated that these cells are responsible for the regeneration of the olfactory epithelium. The epithelium, which enables us to distinguish different smells, is constantly damaged by injuries and inflammation, but it regenerates within a few weeks thanks to OEG cells.

"Damage to the central nervous system is irreversible," says Professor Jarmundowicz. "Yet it has turned out that the glial cells in our noses are the only part of the nervous system capable of regenerating. Paralysed rats with severed spinal cords that received OEG cell transplants began climbing up wire grids again."

Scientists are trying to use this remarkable property of cells from the nose to regenerate damaged fibres in the spinal cord. This offers hope to people with completely severed spinal cords, including victims of car accidents and dives into water that is too shallow.

"Every year in Poland, 700 people end up in wheelchairs for this reason. Until now, there has been no effective way of restoring sensation and motor function in these patients. Intraspinal transplantation of olfactory ensheathing glial cells is a breakthrough in neurosurgery and offers a measure of hope to paralysed people, including our patient," the professor told us yesterday, an hour before the operation.

The 26-year-old man first had olfactory tissue removed from his nose. The epithelium was isolated from it and used to culture OEG cells. The transplant material consisted of a mixture of cells cultured over the previous weeks and cells that had been frozen two years earlier and were now thawed. Yesterday, during a long and painstaking operation involving seven doctors, the patient received 120 injections into his spinal cord. Each contained approximately 25,000 olfactory cells intended to stimulate nerve regeneration. However, it will only become clear after a year whether the man will be able to move his legs.

The operation was preceded by four years of research conducted by scientists from the Department of Neurosurgery at the Medical Academy and the Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences in Wrocław. Through in vitro experiments, studies on rats and research using olfactory epithelium taken from deceased organ donors, the scientists developed a method for collecting, selecting and multiplying cells that subsequently survived in nervous tissue. Their safety was also tested: they did not cause tumours or inflammation in the animals.

"This is an entirely experimental procedure," says Professor Jarmundowicz.

Three such operations have been performed so far in Melbourne, but their results have not yet been announced. Similar operations, using a slightly different method, have been carried out in recent years in Lisbon and London, but the results are still being monitored there as well.

"This is a long process," says the professor. "We are only at the beginning of the road."

Source: Gazeta Wyborcza Wrocław

30.09.2007
Article entitled "Transplants Using Stem Cells Taken from Adult Bone Marrow Restore Functions in Patients with Spinal Cord Injuries; PrimeCell(TM) Therapeutics Announces That Research Will Continue"

Monday, 24 September.
Preliminary results of transplants performed on 38 patients were presented during the annual meeting at the Neurological Congress.

IRVINE, California. PrimeCell(TM) Therapeutics LLC (http://www.primecelltherapeutics.com) announced today that it is supporting research for clinical trials involving the implantation of the patient's own bone marrow-derived stem cells into an injured spinal cord. The reported results of these trials include the recovery of various functions in patients who had been paralysed for between 4 and 22 years.

Dr Luis Geffner presented a preliminary report on the findings on 17 September at the Neurological Congress in San Diego. Between May 2006 and August 2007, 38 patients with spinal cord injuries were treated in Ecuador at Luis Vernaza Hospital in Guayaquil. They received autologous bone marrow stem cells, meaning that the cells were taken from their own bone marrow, collected from the hip bone.

Of the 25 patients monitored for between 3 and 14 months, 15 regained the ability to stand, 10 were able to walk with braces, seven could walk without braces and five could walk using crutches. Three patients regained full bladder control, while 10 experienced the return of some sexual function. No adverse events or abnormal reactions to the implantation were observed.

"Ongoing research will help us clarify the benefits and any possible risks associated with this approach. However, so far, the findings indicate that bone marrow stem cells are safe for patients with spinal cord injuries," said Geffner, head of the stem cell programme at Junta de Beneficencia de Guayaquil.
He emphasised that the work had been completed with the assistance and support of Junta de Beneficencia and Benemérita Sociedad de Lucha Contra el Cáncer (SOLCA), as well as through the support and research carried out by PrimeCell Therapeutics, based in Irvine, California.

"By implanting adult bone marrow stem cells, we have seen significant improvements in the quality of life of people suffering from spinal cord injuries. In addition, we are gaining valuable information that will ultimately help us use other adult cells in the treatment of spinal cord injuries and reprogramme adult embryonic cells," said Francisco Silva, Vice President of Research and Development at PrimeCell Therapeutics. "We are encouraged by the results. This approach may be useful for patients who cannot be treated using conventional medicine."

7.07.2007
Article entitled "Attempts to Repair Spinal Cord Damage"

Hywel Griffith, BBC Wales Health Correspondent.
The trials are to be carried out on the first patients as part of cell research that could help thousands of people paralysed following accidents.
The Welsh charity Trust PA has helped fund scientists who hope to repair the spinal cord by transferring cells from the nose so that they can grow at the site of an injury.
If successful, the treatment could mean that patients regain control over their bodies. The research is being conducted by the Institute of Neurology in London.

Simon Morris, from Sully in the Vale of Glamorgan, has been learning to live a new life since an accident ten years ago left him paralysed from the chest down. A simple fall during a holiday in Greece was enough to damage his spinal cord. He spent 16 months in hospital and is now dependent on a wheelchair.

"I was in the Navy before my accident, so I was quite active. I really enjoyed socialising," said Mr Morris.
"Having all of that taken away in an instant was too much for me."
"Improving my mobility would be brilliant. Any small improvement, however slight, would mean a great deal to me — not just to me, but to other people with spinal cord injuries."

Animal trials

There is currently no treatment for Morris's injury, but Professor Geoffrey Raisman of the Institute of Neurology has said that cells found in the nose can be transplanted into the spinal cord and may help it regenerate.
So far, the tests have been carried out on animals, but Professor Raisman said that the team was ready to begin trials on humans.
"We have reached the point where animal trials — on rats — may allow us to obtain these cells from adult animals," he said.

"We can transplant them into spinal cord injuries, at the spinal roots, and the nerve fibres regenerate and functions return."

"We are now trying to take this approach into human trials," he added.

The stage we and others have reached shows that these cells are present in humans. We are learning how to multiply them using samples taken from volunteers, and then we hope to transplant them into a group of 10–12 patients with high-level spinal cord injuries.
The research is expensive and is supported by a small Welsh charity.

Trust PA was founded in memory of Paul Andre (PA) Blundell, a Cardiff rugby player who was paralysed after an accident on the pitch.

After his death five years ago, his parents decided to support efforts to fund research into spinal cord regeneration.
His mother, Gerri Blundell, said: "We have enormous hope because Geoffrey Raisman's work is backed by 40 years of research.
As far as Paul Andre was concerned, there was a chance that he might walk again before reaching the age of forty. He thought it was worth going through the procedure, and I believe that, for other families, hope is one of the most important things everyone needs in life.
Developing the research may still take years, but financial support will help it move forward. Fundraising events also play a role, including events such as the British Speedway Grand Prix held last weekend."

4.03.2007
Article entitled "A Robotic Skeleton Replaces Muscle Function"

foot A robotic exoskeleton controlled by the user's nervous system may help people regain limb function, which is encouraging news for people with partial impairment of the nervous system, according to researchers from the University of Michigan.

An ankle exoskeleton developed at the University of Michigan was worn by healthy individuals to measure how the device affects ankle function. The University team does not plan to build a commercial exoskeleton, but their findings suggest potential applications in rehabilitation and physical exercise, as the results may be used by other research groups developing similar devices.

"This could benefit patients who have suffered a heart attack, stroke, or certain types of spinal cord injuries," says Daniel Ferris, associate professor at the University of Michigan's School of Kinesiology. "For patients who are able to move slowly, such an assistive device could help them walk faster and more efficiently."

Ferris and Keith Gordon, a former University of Michigan doctoral student who joined the Rehabilitation Institute of Chicago after completing his PhD, demonstrated that people wearing the exoskeleton can learn to walk with the device in approximately 30 minutes. Furthermore, their nervous systems retained the ability to control the exoskeleton even three days later.

Electrical signals sent by the brain to our muscles "tell" them how to move. In people with spinal cord injuries or certain neurological disorders, these signals do not reach their destination with sufficient strength and are poorly coordinated. In addition, patients have a reduced ability to maintain proper control over the direction of their muscle movements, making relearning how to walk extremely difficult.

Conventionally, robotic rehabilitation devices are worn by patients in such a way that the limb is moved by a system receiving instructions from a computer. These devices operate by delivering impulses to help force the body to perform a specific movement.

The invention developed by researchers at the University of Michigan works in the opposite way to conventional rehabilitation aids. In this exoskeleton, electrodes were attached to the volunteer's legs, and the electrical signals sent by the brain were "translated" into movements of the device.

"The (artificial) muscles are pneumatic. When the computer receives an electrical signal from the volunteer's muscle, the pressure in the artificial muscle increases," says Ferris. "Essentially, the artificial muscle contracts together with the human muscle."

Initially, the gait of the person wearing the exoskeleton was disrupted because the mechanical force added by the device increased the overall muscle force. However, within a relatively short time, the volunteer adapted to the additional force and used their natural muscles to a lesser extent, as the exoskeleton was doing more of the work. Their gait returned to normal after 30 minutes.

Ferris believes that the next step is to test the device on patients with impaired muscle function.

The research was funded by the National Institute of Neurological Disorders and Stroke.

9.12.2006
Translated information from the website www.nokha.net of the Iranian institute specialising in the regeneration of damaged spinal cords

Shefa Institute for Spinal Cord Injury Repair.

We use glial cell transplantation in damaged spinal cords.

Spinal Cord Injuries.

Car accidents, falls from heights, explosions and other accidents can cause spinal cord injuries. These events can destroy nerve fibres responsible for transmitting sensory and motor signals, leaving them beyond repair. Consequently, spinal cord injuries are associated with lifelong complications, including limb paralysis, loss of sensation and impaired sphincter and sexual function. However, this is only one side of the tragedy. The other is that people who are unable to walk and are of working age cannot enjoy life, become depressed and cause their families considerable worry.

Statistics.
The number of people worldwide living with spinal cord injuries is estimated at 70 million, and the annual increase is 5 people per 100,000 population.

New Methods of Spinal Cord Repair.

Modern medicine considers spinal cord damage to be irreversible. All medical interventions focus on preventing and treating pressure sores, urinary tract infections and respiratory problems. This lack of progress has prompted many scientists around the world to search for ways to promote the repair of spinal cord injuries.
They believe that the regenerative potential of damaged nerve fibres is inhibited by an unfavourable environment and that changing this environment may allow nerve fibres to regenerate with the help of other cells introduced at the site of injury. Transplantation of various types of cells has demonstrated nerve growth and regeneration in experimental animals with injuries.

Among the promising cell types are Schwann cells.

These supporting cells of the peripheral nervous system play a key role in repairing peripheral nerve injuries, a process that is quite achievable, unlike the repair of spinal cord damage. Numerous laboratory experiments involving animals have shown that Schwann cell transplantation can promote repair in an injured spinal cord.

Project Background.

The transplantation of Schwann cells into patients with spinal cord injuries was preceded by 12 years of scientific and experimental research, the results of which were published in the international scientific journal Neurosci Lett 2006 Jul 10;402(1-2):66-70. Autologous Schwann cell transplantation promotes the healing of damaged tissue and carries a low risk. The initial results are promising.

Advantages.

This method uses Schwann cells taken from the patient, thereby minimising the possibility of transplant rejection and the transmission of viruses. Thanks to the strict safety measures applied during the procedures, none of the nine patients treated experienced adverse effects such as infection, tumour formation or neurological deterioration.

Patient 1
Age: 36
Cause of injury: gunshot wound
Date of injury: 1987
Sensation before surgery: T11; no sensation below the groin
Motor function before surgery: no limb movement
Sphincter function before surgery: no control
Date of surgery: February 2006
Sensation after surgery: return of sensation in the extremities
Motor function after surgery: slight knee flexion
Sphincter function after surgery: controlled

Patient 2
Age: 27
Cause of injury: fall
Date of injury: 1993
Sensation before surgery: no sensation below the knee
Motor function before surgery: hip and thigh muscles
Sphincter function before surgery: no control
Date of surgery: March 2006
Sensation after surgery: return of full sensation in the lower part of the limb
Motor function after surgery: voluntary movement of the thigh
Sphincter function after surgery: "increased dry interval"

Patient 3
Age: 25
Cause of injury: car accident
Date of injury: 2001
Sensation before surgery: no sensation from the upper thigh downwards
Motor function before surgery: no movement whatsoever
Sphincter function before surgery: controlled
Date of surgery: May 2006
Sensation after surgery: improved
Motor function after surgery: slight knee movement
Sphincter function after surgery: controlled

Patient 4
Age: 25
Cause of injury: car accident
Date of injury: 1993
Sensation before surgery: normal
Motor function before surgery: movement in the affected arms
Sphincter function before surgery: controlled
Date of surgery: May 2006
Sensation after surgery: normal
Motor function after surgery: increased strength in the left arm, slight movement in the right arm, and movement in the toes and ankles of both feet
Sphincter function after surgery: controlled

12.09.2006
Information on spinal cord regeneration provided by a participant in the American CareCure discussion forum, concerning experiments in Iran.

"Here is what I know about their human research.
They conducted experiments on nine people. First, they carried out experiments on rats, and after obtaining excellent results, the Ethics Department of the Ministry of Health granted them permission to conduct trials on 30 people.
After conducting trials on nine people, the results were so good that they decided to inform the media about their findings and announced that they would soon present the results to the medical community (I don't know when this will happen).
Here is what they did: they took stem cells from the back of the patient's lower leg (below the knee) and cultured them in a sterile laboratory. The cells were then injected into the site of the spinal cord injury. The cell culture period ranges from three weeks to 45 days.
What I have learned about the results is that there have been no side effects.
All 9 out of 9 patients have regained control of their bowels and bladder. Four of them are able to stand and have regained some sensation and movement, and this is only a few months after transplantation. Progress is still being made. Dr Hooshang Saberi said that improvement may continue for a year or longer and that physical therapy after transplantation is essential.
They will reserve the remaining 21 places out of the 30 (the number of patients approved for treatment by the Ethics Department of the Ministry of Health), as they expect to obtain permission to treat additional people. They said they are preparing facilities and training other doctors to provide treatment on a larger scale.
The number of years since the injury does not matter. Among the people who underwent the experimental procedure were individuals who had sustained spinal cord injuries 13 and 16 years earlier.
They treat people up to the age of 50.
The spinal cord must not be completely severed (it must not consist of two separate pieces), and the site of injury must not be too extensive.
They perform tests on a muscle and a nerve below the level of injury to make sure that the nerves and muscles below the injury are in good condition. For example, they said that a person who has spasticity below the level of injury is a better candidate because their muscles and nerves are functioning below the level of the injury.
They recommend keeping the muscles in good condition in order to be ready for this treatment."

20.07.2006
Article from Rzeczpospolita entitled "A Revitalising Bath for Nerves"

Bacteria may help in the process of spinal cord repair – American scientists report.
Doctors are still powerless when it comes to spinal cord injuries.
(c) MIROSŁAW ŁOBACZEWSKI
Unlike, for example, the nerves in a finger, nerves in the spinal cord do not regenerate when they are severed. This is because their immediate surroundings produce substances that inhibit nerve growth. However, the action of these natural substances can be neutralised. Neurologists at Johns Hopkins University have succeeded in doing so. They used an enzyme called sialidase, which is produced by bacteria.
Before the experiment, the scientists severed the nerves of laboratory rats at the point where nerves branch off from the spinal cord and extend to the front paws. Similar injuries frequently occur in humans as a result of motorcycle accidents. Comparable damage can also occur in newborn babies.
The researchers implanted tiny pumps in the rats that continuously delivered sialidase to the site of nerve damage. It turned out that this procedure more than doubled the rate at which nerve connections regenerated. Further research will determine whether the regenerated nerves have taken over the functions of the severed connections.